BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $891,378 | +19.3% | 8,205 | +18.5% | 0.00% | 0.0% |
Q2 2023 | $747,377 | -23.4% | 6,925 | -11.6% | 0.00% | -50.0% |
Q1 2023 | $975,603 | -23.7% | 7,831 | -8.1% | 0.00% | -33.3% |
Q4 2022 | $1,279,091 | +3.2% | 8,517 | -7.3% | 0.00% | 0.0% |
Q3 2022 | $1,239,000 | -15.2% | 9,183 | -6.4% | 0.00% | 0.0% |
Q2 2022 | $1,461,000 | -20.3% | 9,808 | -1.1% | 0.00% | -25.0% |
Q1 2022 | $1,832,000 | -79.1% | 9,922 | -70.8% | 0.00% | -76.5% |
Q4 2021 | $8,747,000 | -14.9% | 33,949 | -9.8% | 0.02% | -19.0% |
Q3 2021 | $10,275,000 | +18.4% | 37,655 | -2.8% | 0.02% | +10.5% |
Q2 2021 | $8,676,000 | +378.3% | 38,757 | +133.2% | 0.02% | +375.0% |
Q1 2021 | $1,814,000 | +91.6% | 16,623 | +43.0% | 0.00% | +33.3% |
Q4 2020 | $947,000 | +105.4% | 11,624 | +74.6% | 0.00% | +200.0% |
Q3 2020 | $461,000 | +880.9% | 6,656 | +845.5% | 0.00% | – |
Q2 2020 | $47,000 | – | 704 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
Robbins Farley | 13,220 | $2,255,000 | 1.70% |
APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |